Healthcare

Bausch Health Addresses Bankruptcy Speculation, Affirms No Plans for...

Headlines:,Bausch Health responds to bankruptcy,rumors,, clarifying that it is not contemplating bankruptcy.,The company emphasizes its commitment to,...

This Weight Loss Drug Candidate Could Impact Pfizer’s Future Prospec...

Pfizer Inc.,(NASDAQ:PFE),is currently facing challenges in terms of growth, with its stock down more than 25% over the past three years. The company's...

HCA Healthcare Stock Soars as Company Exceeds Expectations and Upgra...

Summary:,- HCA Healthcare's stock increased by over 5% on Tuesday.,- The company's performance exceeded expectations.,- HCA Healthcare raised its full...

Novo Nordisk’s Wegovy approved by MHRA in the UK for cardiovascular...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s weight loss drug, Wegovy, for the preventi...

Novartis (SWX: NOVN) Reports Robust Q2 Growth, Raises FY 2024 Guidan...

Novartis (SWX: NOVN) has delivered strong financial results in the second quarter of 2024, leading to a raised full-year bottom-line guidance. The com...

GE HealthCare (Nasdaq: GEHC) Expands AI Capabilities with Intelligen...

GE Healthcare (Nasdaq: GEHC) has announced a strategic acquisition aimed at bolstering its capabilities in clinical artificial intelligence (AI) softw...

UnitedHealth Group (NYSE: UNH) Reports Strong Second Quarter 2024 Re...

UnitedHealth Group (,NYSE: UNH,) has announced its second quarter 2024 financial results, demonstrating robust performance driven by significant growt...

UnitedHealth Q2 profit beats expectations amid recovery from tech un...

UnitedHealth Group (NYSE: UNH) announced a stronger-than-anticipated second-quarter profit on Tuesday, driven by robust performance in its healthcare...

Mainz Biomed N.V. (NASDAQ: MYNZ), Pursues Breakthrough Device Design...

Mainz Biomed N.V. (,NASDAQ: MYNZ,), a frontrunner in molecular genetics diagnostics with a focus on early cancer detection, has reached a pivotal mile...

Grifols Founding Family and Brookfield team up for potential €5.5B t...

The Grifols founding family and Canadian alternative asset manager Brookfield have joined forces to launch a potential takeover bid for Spanish pharma...

Mediwound stock soars 60% on takeover interest

Mediwound Ltd (NASDAQ: MDWD) rallied a whopping 60% on Friday following a report that Solventum Corp (NYSE: SOLV) is interested in buying the biopharm...

Novo Nordisk reprimanded by UK for failing to disclose £7.9 M in pay...

In an industry where transparency is paramount, Novo Nordisk, the Danish pharmaceutical giant known for its diabetes drug Ozempic and weight-loss trea...

Well Health stock price rare pattern points to more upside

The Well Health Technologies (TSX: WELL) stock price has done well in the past few weeks, making it one of the best-performing companies in Canada rec...

Bad news for Novo Nordisk weight-loss drug Wegovy

Novo Nordisk A/S (CPH: NOVO-B) is in the green today even though a Harvard study said its weight loss drug may increase the risk of nonarteritic anter...

How much could the Alzheimer’s drug add to Eli Lilly’s revenue?

The new Alzheimer’s drug is unlikely to benefit shares of Eli Lilly & Co (NYSE: LLY) as quickly as its weight-loss drug, says Evan Seigerman. He’s...

Eli Lilly receives FDA approval for its Alzheimer’s drug Kisunla

Eli Lilly & Co (NYSE: LLY) received approval for its Alzheimer’s drug from the Food & Drug Administration on Tuesday.  The development is...

CVS Health stock price analysis as Walgreens implodes

CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 202...

GSK’s (LSE/NYSE: GSK) Omjjara Approved in Japan for Myelofibrosis Tr...

GSK plc (LSE/,NYSE: GSK,) has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatmen...

Zealand Pharma stock rallies 20%: what happened?

Zealand Pharma (CPH: ZEAL) rallied more than 20% this morning after reporting positive results from an early stage trial of its new weight loss treatm...

Why has the Sarepta stock price (SRPT) gone up more than 35%?

Sarepta Therapeutics (NASDAQ: SRPT), a pharmaceutical company that describes itself as specializing in “precision genetic medicine for rare diseases”,...